EC Announces New Plan to Roll Out In Vitro Diagnostic Regulation
...
Already a member? Log in here
The Business of Testing-dtet
Major Insurer Claims It Has No Obligation to Pay for Pooled COVID-19 Testing
...
Already a member? Log in here
Pandemic Energizes Search for Genomics-Based Early PTSD Detection Diagnostics
...
Already a member? Log in here
New COVID-19 Revenues Not Enough to Offset Declines in Elective & Screening Tests
...
Already a member? Log in here
Test Utilization: Payment Policies More Effective than Practice Recommendations in Curbing Orders of Low-Value Tests
...
Already a member? Log in here
Genetics Update: 23andMe Seeks to Upend the Medical Industry via Genetic Testing Information Sharing
...
Already a member? Log in here
Upfront Next-Generation Sequencing for Lung Cancer Patients Saves Time, Money
From – Diagnostic Testing & Emerging Technologies
Use of upfront next-generation sequencing (NGS) testing at diagnosis of patients with metastatic non-small-cell lung cancer (mNSCLC) is…
Already a member? Log in here
Guidelines at a Glance
...
Already a member? Log in here
Preventive Genomic Screening In Young Adults Highly Cost Effective
...
Already a member? Log in here
Study Showing PGx Testing Improves Depression Outcomes, Key to Myriad’s Reimbursement Strategy
From – Diagnostic Testing & Emerging Technologies
Pharmacogenomic testing (PGx) provides clinically meaningful improvement in response and remission rates for difficult-to-treat depression patients over standard of care, according to…
Already a member? Log in here